All Stories
- Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels
Article
- Opioid-Related Respiratory Depression in Non-Cancer Patients, as Reported in the Japanese Adverse Drug Event Report Database
Article
- Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey
Article
- Cancer Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other Than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey
Article
- Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer
Article
- Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study
- A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer
- Polypharmacy & Pharmacists; Multicenter Prospective Study Demonstrates Benefits of Interventions
Article
- Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study
Article
- Pain accompanying photoimmunotherapy for head and neck cancer
Article
- Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
- Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications
- ISOPP Standards for the Safe Handling of Cytotoxics
- Needs of chemotherapy regimen checks procedure: from the survey on chemotherapy regimen checks performed by pharmacists in hospitals other than designated cancer hospitals in Japan
- MO8-5 Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer
- Drug cost savings resulting from the outpatient pharmacy services collaborating with oncologists at outpatient clinics
Article
- Grade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125...
Article
- Impact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib
- Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database
- A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan
Article
- Analyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report Database
- Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database
- A nationwide survey of community pharmacist contributions to polypharmacy in opioid-using and non-using cancer patients in Japan
- Impact of outpatient pharmacy services collaborating with oncologists at an outpatient clinic for outpatient chemotherapy prescription orders
- Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
Article
- Impact of pharmacy collaborating services in an outpatient clinic on improving adverse drug reactions in outpatient cancer chemotherapy
- Current status of drug vial optimization use to prevent waste associated with injectable anticancer agents
- Comparative evaluation of a website for drug incompatibility
- ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
- SPS-3Impact of clinical pharmacists collaborating with oncologists in outpatient cancer chemotherapy on cost of chemotherapy
- Retrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
- Opportunities to significantly reduce expenditure associated with cancer drugs
- Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan
- Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
- The impact of pharmacist certification on the quality of chemotherapy in Japan
- Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin
- P2-088Impact of pharmacist outpatient interventions on management of Lenvatinib for thyroid cancer patients
- Places to Managing Medicines Patients Brought in Hospital: Which is Better Central Pharmacy or Hospital Wards?
- Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy
- P2-9-52Retrospective analysis of anti-allergy prophylaxis for infusion reactions of cetuximab in head and neck cancer patients
- P2-9-11Retrospective analysis of emergency hospital admission due to chemoradiotherapy for head and neck cancer patients
- ソラフェニブによる手足症候群に対する尿素配合軟膏の予防投与の有効性
- O1-18-6CETUXIMAB INFUSION REACTIONS IN JAPANESE HEAD AND NECK CANCER PATIENTS
- 998PINCIDENCE AND RISK FACTORS OF HYPOMAGNESEMIA IN HEAD AND NECK CANCER PATIENTS TREATED WITH CETUXIMAB
- Evaluation of the impact of a flowchart-type leaflet for cancer inpatients
- P1-100 * SURVEY OF PHARMACISTS' INVOLVEMENT IN CANCER TREATMENT IN CANCER MEDICINE COOPERATION BASE AND GENERAL HOSPITALS
- P1-101 * ACTUAL SITUATION AND MULTIFACTORIAL ANALYSIS OF STANDARD CANCER CHEMOTHERAPY REGIMEN USE IN JAPAN
- O1-100 * EVALUATION OF PROPHYLACTIC TETRACYCLINES USE IN CETUXIMAB CHEMOTHERAPY FOR HEAD AND NECK CANCER
- Survey of Pharmacists Involved in Cancer Treatment in Cancer Medicine Cooperation Base Hospitals
- Evaluation of nausea and vomiting in radiation plus concurrent weekly cisplatin (weekly CDDP+RT) without prophylactic aprepitant in head and neck cancer
- Risk Factor of the Hand/foot Skin Reaction Induced by Sorafenib in Patients with Advanced Hepatocellular Carcinoma
- LB023-SUN A NON-RANDOMIZED COMPARISON OF TUBE FEEDING OF ELEMENTAL DIET AND LOW RESIDUE DIET IN HEAD AND NECK CANCER PATIENTS DURING CONCURRENT CHEMORADIOTHERAPY
- Evaluation of a team-based clinical pharmacist in cancer chemotherapy.
- Adherence in Use of Oral Antibiotics for Fever in Outpatient Docetaxel Chemotherapy
- Survey on Opioid and Psychotic Use by Cancer Patients
- Evaluation of Improvement of Adherence Following Pharmacist Intervention for Hand/Foot Skin Reactions Induced by Sorafenib